Jazz sues FDA, HHS over ri­val nar­colep­sy drug ap­proval

Jazz Phar­ma­ceu­ti­cals is su­ing the FDA and HHS in fed­er­al court, ask­ing a judge to block what it called an “un­law­ful” ap­proval by fed­er­al reg­u­la­tors of a ri­val nar­colep­sy prod­uct.

Jazz filed a law­suit against the agen­cies in US Dis­trict Court for the Dis­trict of Co­lum­bia Thurs­day, al­leg­ing the ap­proval of Avadel Phar­ma­ceu­ti­cals’ Lum­ryz, a ri­val prod­uct to its own nar­colep­sy drug, is un­law­ful due to pro­tec­tions on its own drug un­der the Or­phan Drug Act (ODA).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER